tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Rigel Pharmaceuticals target adjusted to $57 from $15 at H.C. Wainwright

H.C. Wainwright analyst Joseph Pantginis adjusted the firm’s price target on Rigel Pharmaceuticals to $57 from $15 and keeps a Buy rating on the shares to reflect the one-for-20 reverse split.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1